| The global threat of antimicrobial resistance: science for intervention I Roca, M Akova, F Baquero, J Carlet, M Cavaleri, S Coenen, J Cohen, ... New microbes and new infections 6, 22-29, 2015 | 1318 | 2015 |
| Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines KN Agwuh, A MacGowan Journal of Antimicrobial Chemotherapy 58 (2), 256-265, 2006 | 920 | 2006 |
| EUCAST expert rules in antimicrobial susceptibility testing R Leclercq, R Cantón, DFJ Brown, CG Giske, P Heisig, AP MacGowan, ... Clinical microbiology and infection 19 (2), 141-160, 2013 | 864 | 2013 |
| Development of the quinolones MI Andersson, AP MacGowan Journal of Antimicrobial Chemotherapy 51 (suppl_1), 1-11, 2003 | 757 | 2003 |
| A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital M Wootton, RA Howe, R Hillman, TR Walsh, PM Bennett, AP MacGowan Journal of Antimicrobial Chemotherapy 47 (4), 399-403, 2001 | 529 | 2001 |
| The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee MJ Ellington, O Ekelund, FM Aarestrup, R Canton, M Doumith, C Giske, ... Clinical microbiology and infection 23 (1), 2-22, 2017 | 526 | 2017 |
| European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria G Kahlmeter, DFJ Brown, FW Goldstein, AP MacGowan, JW Mouton, ... Journal of antimicrobial chemotherapy 52 (2), 145-148, 2003 | 475 | 2003 |
| Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides TR Walsh, A Bolmström, A Qwärnström, P Ho, M Wootton, RA Howe, ... Journal of clinical microbiology 39 (7), 2439-2444, 2001 | 395 | 2001 |
| Antibiotic treatment of gram-positive bone and joint infections ESR Darley, AP MacGowan Journal of antimicrobial chemotherapy 53 (6), 928-935, 2004 | 359 | 2004 |
| Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections AP MacGowan Journal of Antimicrobial Chemotherapy 51 (suppl_2), ii17-ii25, 2003 | 355 | 2003 |
| The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach JW Mouton, DFJ Brown, P Apfalter, R Cantón, CG Giske, M Ivanova, ... Clinical Microbiology and Infection 18 (3), E37-E45, 2012 | 327 | 2012 |
| Antibiotic resistance A MacGowan, E Macnaughton Medicine 45 (10), 622-628, 2017 | 273 | 2017 |
| Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective JW Mouton, PG Ambrose, R Canton, GL Drusano, S Harbarth, ... Drug Resistance Updates 14 (2), 107-117, 2011 | 257 | 2011 |
| Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests AP MacGowan, R Wise Journal of Antimicrobial Chemotherapy 48 (suppl_1), 17-28, 2001 | 256 | 2001 |
| The occurrence and seasonal changes in the isolation of Listeria spp. in shop bought food stuffs, human faeces, sewage and soil from urban sources AP MacGowan, K Bowker, J McLauchlin, PM Bennett, DS Reeves International journal of food microbiology 21 (4), 325-334, 1994 | 237 | 1994 |
| Sequence analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia TR Walsh, L Hall, SJ Assinder, WW Nichols, SJ Cartwright, AP MacGowan, ... Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression 1218 (2 …, 1994 | 233 | 1994 |
| Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001–2002: the BSAC Bacteraemia Resistance Surveillance Programme R Reynolds, N Potz, M Colman, A Williams, D Livermore, A MacGowan Journal of Antimicrobial Chemotherapy 53 (6), 1018-1032, 2004 | 226 | 2004 |
| Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement AM Lovering, J Zhang, GC Bannister, BJA Lankester, JHM Brown, ... Journal of Antimicrobial Chemotherapy 50 (1), 73-77, 2002 | 222 | 2002 |
| European Committee on Antimicrobial Susceptibility Testing (EUCAST) technical notes on antimicrobial susceptibility testing G Kahlmeter, DFJ Brown, FW Goldstein, AP MacGowan, JW Mouton, ... Clinical Microbiology and Infection 12 (6), 501-503, 2006 | 218 | 2006 |
| Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia TR Walsh, AP MacGowan, PM Bennett Antimicrobial agents and chemotherapy 41 (7), 1460-1464, 1997 | 186 | 1997 |
RAFAEL CANTONJefe de Servicio de Microbiología Hospital Ramón y Cajal在 salud.madrid.org 的电子邮件经过验证
